SECH Albioma

Albioma : Combined General Meeting of 29 May 2020 - Availability of the preparatory documents

Albioma : Combined General Meeting of 29 May 2020 - Availability of the preparatory documents

Press release

Paris La Défense, 1 May 2020

Combined General Meeting of 29 May 2020

Availability of the preparatory documents

In connection with the forthcoming Combined General Meeting that will be held exceptionally behind closed doors, excluding the physical presence of the shareholders on 29 May 2020, at 3:00 pm (Paris Time), Albioma announces that the preparatory documents have been made available to its shareholders. These documents may be consulted on the Company’s website, (section Finance/General Meetings of shareholders).

Furthermore, any shareholder may obtain free copies of these documents, upon simple written request sent either to the Company, by sending an email to ,  or to the General Meeting coordinator (BNP Paribas Securities Services, CTS Assemblées Générales, Les Grands Moulins, 9 rue du Débarcadère, 93761 Pantin Cedex, France), until the fifth day preceding the General Meeting; in order to exercise such a right, any holder of bearer shares must provide a registration certificate.

In view of the extension of the confinement measures put in place by the French government to stem the Covid-19 epidemic, the shareholders will not be able to read the preparatory documents at the Company’s head office.

Albioma’s shareholders will be able to vote via Internet at the General Meeting of Shareholders, using the Votacess platform (opening on 13 May 2020). Detailed information on the Internet voting procedure is available on Albioma’s website, (section Finance/General Meetings of shareholders).

Next on the agenda: annual General Meeting of shareholders, on 29 May 2020, at 3 pm (CET).

About AlbiomaContacts
An independent renewable energy producer, Albioma is committed to the energy transition thanks to biomass and photovoltaics.



The Group, which is established in Overseas France, Mauritius and Brazil, has developed a unique partnership for 25 years with the sugar industry, to produce renewable energy from bagasse, a fibrous residue from sugar cane.



Albioma is also the leading generator of photovoltaic power overseas where it constructs and operates innovative projects with integrated storage capabilities.
Investor

Julien Gauthier

+33 (0)1 47 76 67 00



Media

Charlotte Neuvy

+33 (0)1 47 76 66 65

  
Albioma shares are listed on EURONEXT PARIS (sub B) and eligible for the deferred settlement service (SRD) and PEA-PME plans (ISIN FR0000060402 – ticker: ABIO).



 

Attachment

EN
01/05/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Albioma

 PRESS RELEASE

Albioma : Press release relating to the squeeze-out procedure for the ...

Albioma : Press release relating to the squeeze-out procedure for the shares and warrants of Albioma PRESS RELEASE DATED SEPTEMBER 29, 2022 RELATING TO THE SQUEEZE-OUT PROCEDURE FOR THE SHARES AND WARRANTS OF ALBIOMA FOLLOWING THE PUBLIC TENDER OFFER INITIATED BY KYOTO BIDCO SAS AMOUNT OF INDEMNIFICATION: 50 euros per Albioma share (ex-dividend) 29,10 euros per Albioma Warrant This press release was prepared and distributed by Kyoto BidCo SAS in accordance with the provisions of Article 237-3 III of the General Regulation of the French Autorité des Marchés Fi...

 PRESS RELEASE

ALBIOMA : Communiqué relatif à la mise en œuvre du retrait obligatoire...

ALBIOMA : Communiqué relatif à la mise en œuvre du retrait obligatoire visant les actions et les BSAAR de la société Albioma Ce communiqué ne constitue pas une offre d’acquisition de titres. COMMUNIQUÉ DE PRESSE DU 29 SEPTEMBRE 2022RELATIF À LA MISE EN OEUVRE DU RETRAIT OBLIGATOIRE VISANT LES ACTIONS ET LES BSAAR DE LA SOCIÉTÉ ALBIOMACONSÉCUTIVEMENT À L’OFFRE PUBLIQUE D’ACHATINITIÉE PARKYOTO BIDCO SAS MONTANT DE L’INDEMNISATION : 50 euros par action Albioma (dividende détaché) 29,10 euros par bon de souscription et/ou d’acquisition d’actions remboursables Albioma Le présent communiqué...

Gaetan Calabro ... (+5)
  • Gaetan Calabro
  • Jeremy Sallee
  • Maxence Dhoury
  • Mohamed Kaabouni
  • Nicolas Royot

La Matinale - 2022-09-15

LA VALEUR DU JOUR : PRODWAYS : Des résultats semestriels exceptionnels / Contact – Acheter (1), obj. 4.00€ Cours: 3.28€ au 14/09/22 ALBIOMA : Vers un retrait de cote Cours: 47.1€ au 14/09/22 CARMAT : Confiant sur la reprise – Acheter (1), obj. 29.0€ Cours: 12.8€ au 14/09/22 ESKER : Un discours (trop?) prudent – Acheter (1), obj. 189.0€ Cours: 131.7€ au 14/09/22 INNATE PHARMA : Horizon de trésorerie confortable et de nouveaux projets à venir – Acheter (1), obj. 6.20€ Cours: 2.58€ au 14/09/22....

 PRESS RELEASE

Albioma : Success of the friendly Tender Offer initiated by KKR

Albioma : Success of the friendly Tender Offer initiated by KKR PRESS RELEASE Paris La Défense, 15 September 2022 Success of the friendly Tender Offer initiated by KKR KKR now holds 92.19% of Albioma’s capital Albioma and KKR announce the results of the friendly Tender Offer for all Albioma securities (the “Offer”) published by the Autorité des marchés financiers (“AMF”) following the closure of the second offer period on 9 September 2022. Following the closure of the second offer period initiated by KKR, 2.536.724 shares and 223 warrants (BSAAR) were tendered. Fol...

 PRESS RELEASE

ALBIOMA : Succès de l'Offre Publique d'Achat amicale initiée par KKR s...

ALBIOMA : Succès de l'Offre Publique d'Achat amicale initiée par KKR sur Albioma Communiqué de presse Paris La Défense, le 15 septembre 2022 Succès de l'Offre Publique d'Achat amicale initiée par KKR sur Albioma KKR détient désormais 92,19% du capital d’Albioma Albioma et KKR annoncent les résultats de l’Offre Publique d’Achat amicale sur l’ensemble des titres d’Albioma (l’« Offre ») publiés par l'Autorité des marchés financiers (« AMF ») à la suite de la clôture de l'Offre rouverte le 9 septembre 2022. A la suite de la clôture de l’Offre rouverte initiée par KK...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch